AlphaYouKA
Insider selling
Kristin Abate sold $38 of Karyopharm Therapeutics Inc. (KPTI) stock
Kristin Abate, Chief Accounting Officer of Karyopharm Therapeutics Inc. (KPTI), sold 19 shares of KPTI stock worth $38, per an SEC Form 4 filed Sep 2, 2026.
It was an open-market sale.
The trade happened on Sep 1, 2026, 1 day before it was made public.
KPTI has moved +0.5% since the trade date, from $1.85 to $1.86 (Sep 21, 2026 close).
- Traded
- Sep 1, 2026
- Disclosed
- Sep 2, 2026
- Filing delay
- 1 day
- Price since
- +0.5%
- Role
- Chief Accounting Officer
- Source
- SEC Form 4
More KPTI insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.